Phcedehop Pharmaceutical Import Profile — Algeria (DGFT 2022–2026)

Name: Phcedehop Pharmaceutical Import Records from India — 2 Products, $282.4K FOB USD (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Phcedehop — Pharmaceutical Importer Profile (2026) | 2 Products, $282.4K Trade | TransData Nexus

Phcedehop

Pharmaceutical Importer · Algeria · Advanced Oncology Focus · $282.4K Total Trade · DGFT Verified

Phcedehop is a pharmaceutical importer based in Algeria with a total trade value of $282.4K across 2 products in 1 therapeutic categories. Based on 9 verified import shipments from Indian Customs (DGFT) records, the company actively imports across multiple product segments. Phcedehop sources from 1 verified Indian supplier, with Bdr Pharmaceuticals International Private Limited accounting for 100.0% of imports.

Phcedehop — Import Portfolio & Supplier Network

Phcedehop import network — 2 products from Indian suppliers. Source: Indian Customs (DGFT).

Who Are the Verified Indian Suppliers to Phcedehop?

Customs-verified supplier relationships from Indian DGFT records

Supplier	Value	Shipments	Share
Bdr Pharmaceuticals International Private Limited	$538.7K	23	100.0%

Phcedehop sources from 1 verified Indian supplier across 16 distinct formulations. The sourcing is highly concentrated — Bdr Pharmaceuticals International Private Limited accounts for 100.0% of total imports, indicating a strategic single-source relationship.

What Formulations Does Phcedehop Import?

Formulation	Value	Ships
Caspofungin acetate INJ 50MG (other)(tax inv#mh2511600017 dt:15.04.2025)	$100.0K	2
Caspofungin acetate INJ 70MG (other)(tax inv#mh2511600017 dt:15.04.2025)	$100.0K	2
Cabazitaxel INJ 60MG 1 5ML z texel other tax inv mh2511600084 dt 22 05	$50.0K	1
Thalidomide 100 MG capsules (other) (tax inv# mh2411600638 dt: 28.03.2025)	$48.3K	1
Thalidomide 100 MG gles (other) (tax inv# mh1160000622 dt: 11.03.2024)	$47.6K	1
Cabazitaxel INJ 60MG 1 5ML z texel other tax inv mh2511600086 dt 22 05	$45.2K	1
Thalidomide 100 MG gles othertax invmh1160000321 dt	$41.7K	2
Thalidomide 100 MG gles othertax invmh1160000282 dt	$27.2K	1
Thalidomide 50 MG gles othertax invmh1160000321 dt	$23.7K	2
Thalidomide 50 MG gles (other) (tax inv# mh1160000622 dt: 11.03.2024)	$18.6K	2
Thalidomide 50 MG gles othertax invmh1160000282 dt	$18.4K	2
Thalidomide 50 MG capsules(other) (tax inv# mh2411600638 dt: 28.03.2025)	$18.0K	1
10 vials of 70 MG and 10 vials of 50MG as	$0	2
Bdomide 100 MG 20 blister and 50 MG 20 blister as foc othertax document mh1160000321 dt	$0	1
Thalidomide 100MG qty 40 blister and thalidomide 50MG qty 20 blisteras foc (other) (tax inv# mh2411600638	$0	1

Import Portfolio — Top 2 by Import Value

#	Product	Category	Value	Ships	Share	Rk
1	Cabazitaxel	Advanced Oncology	$150.0K	3	1.6%	10
2	Thalidomide	Advanced Oncology	$132.4K	6	6.8%	4

Phcedehop imports 2 pharmaceutical products across 1 categories into Algeria totaling $282.4K.

Phcedehop — Corporate Profile & Information

Company type, headquarters, distribution network, and industry role

1Company Overview

Phcedehop, officially known as Pharmacie Centrale des Hôpitaux, is a prominent pharmaceutical importer and distributor based in Algiers, Algeria. Established to serve the healthcare sector, Phcedehop plays a pivotal role in ensuring the availability of essential medications across the country. The company operates as a state-owned entity, directly managed by the Ministry of Health, and functions as the central procurement and distribution arm for public hospitals and healthcare facilities in Algeria. This centralized approach allows Phcedehop to streamline the acquisition and distribution of pharmaceutical products, ensuring equitable access to medicines nationwide.

In its capacity, Phcedehop collaborates with various international suppliers to meet the diverse pharmaceutical needs of Algeria's public healthcare system. The company's operations encompass the importation, storage, and distribution of a wide range of pharmaceutical products, including finished formulations such as tablets, capsules, syrups, and injections. By maintaining a robust supply chain, Phcedehop ensures that public healthcare institutions are well-equipped to provide quality care to patients across the country.

2Distribution Network

Phcedehop's distribution network is strategically designed to ensure efficient delivery of pharmaceutical products throughout Algeria. The company's primary warehouse is located in Darel Beida, Algiers, serving as the central hub for storage and distribution operations. From this central location, Phcedehop dispatches medications to various regional warehouses and directly to public hospitals and healthcare facilities across the country. This centralized distribution model enables the company to maintain stringent quality control and inventory management, ensuring timely and accurate delivery of pharmaceutical products.

In addition to its domestic distribution capabilities, Phcedehop has established partnerships with international suppliers to source a diverse range of pharmaceutical products. These collaborations facilitate the importation of essential medications, including specialized treatments not produced locally, thereby enhancing the overall healthcare provision in Algeria. By leveraging its distribution network and international partnerships, Phcedehop plays a crucial role in maintaining a steady supply of quality pharmaceuticals to meet the needs of Algeria's public healthcare system.

3Industry Role

Phcedehop holds a central position in Algeria's pharmaceutical supply chain, primarily functioning as the main importer and distributor for the public healthcare sector. As a state-owned entity, it is responsible for sourcing, importing, and distributing a comprehensive range of pharmaceutical products to public hospitals and healthcare facilities across the country. This role is critical in ensuring that the public sector has access to necessary medications, including those not produced domestically.

By centralizing procurement and distribution, Phcedehop aims to achieve economies of scale, reduce costs, and ensure equitable access to medicines throughout Algeria. Its operations are closely aligned with national health policies and objectives, reflecting the government's commitment to providing quality healthcare services to all citizens. Through its strategic position, Phcedehop contributes significantly to the stability and resilience of Algeria's healthcare supply chain.

TransData Nexus Research · Company registries, industry databasesMar 2026

Supplier Relationship Intelligence — Phcedehop

Sourcing concentration, supply chain resilience, and strategic implications

1Sourcing Concentration Analysis

Phcedehop's sourcing strategy exhibits a high degree of concentration, with a significant portion of its pharmaceutical imports originating from a single supplier: BDR Pharmaceuticals International Private Limited. This supplier has accounted for 100% of Phcedehop's pharmaceutical imports from India, amounting to $539,000 across 23 shipments. The top two imported products from this supplier are Cabazitaxel and Thalidomide, which together constitute the entire import portfolio.

This sourcing concentration indicates a strategic choice by Phcedehop to establish a strong, reliable partnership with BDR Pharmaceuticals, ensuring consistent quality and supply of critical medications. However, such dependency on a single supplier also introduces potential risks, including supply chain disruptions due to geopolitical issues, regulatory changes, or operational challenges faced by the supplier. To mitigate these risks, it would be prudent for Phcedehop to consider diversifying its supplier base, thereby enhancing the resilience and flexibility of its supply chain.

2Supply Chain Resilience

Phcedehop's supply chain resilience is closely tied to its exclusive partnership with BDR Pharmaceuticals International Private Limited. While this relationship ensures a steady supply of essential medications, it also means that any disruptions affecting BDR Pharmaceuticals could significantly impact Phcedehop's ability to meet the pharmaceutical needs of Algeria's public healthcare sector.

Importing Pharmaceuticals into Algeria — Regulatory Framework

Regulatory authority, GMP requirements, import licensing for Algeria

1Regulatory Authority & Framework

The primary regulatory authority overseeing pharmaceutical imports in Algeria is the Ministry of Pharmaceutical Industry. This ministry is responsible for establishing and enforcing regulations related to the importation, distribution, and marketing of pharmaceutical products within the country. In October 2025, the Ministry issued Decree No. 24, which outlines the requirements, procedures, and compliance obligations for licensing pharmaceutical import establishments in Algeria. This decree modernized the application process and strengthened oversight of pharmaceutical import activities, replacing the previous decree from December 2021.

The regulatory framework established by the Ministry of Pharmaceutical Industry aims to ensure that all pharmaceutical products imported into Algeria meet the necessary quality, safety, and efficacy standards. This includes compliance with Good Manufacturing Practices (GMP) and adherence to labeling and packaging requirements. By enforcing these regulations, the Ministry seeks to protect public health and maintain the integrity of the pharmaceutical supply chain in Algeria.

2Import Licensing & GMP

Import licensing requirements for pharmaceutical products in Algeria are governed by the Ministry of Pharmaceutical Industry. As per Decree No. 24 issued in October 2025, pharmaceutical import establishments must obtain authorization from the Ministry to operate legally. The application process involves submitting a comprehensive dossier that includes details about the establishment, the products intended for import, and evidence of compliance with GMP standards. Authorized import establishments are required to maintain records of all purchase and sales transactions and submit an annual import report by January 31 of the following year.

Frequently Asked Questions — Phcedehop

What products does Phcedehop import from India?

Phcedehop imports 2 pharmaceutical products across 1 categories. Top imports: Cabazitaxel ($150.0K), Thalidomide ($132.4K).

Who supplies pharmaceuticals to Phcedehop from India?

Phcedehop sources from 1 verified Indian suppliers. The primary supplier is Bdr Pharmaceuticals International Private Limited (100.0% of imports, $538.7K).

What is Phcedehop's total pharmaceutical import value?

Phcedehop's total pharmaceutical import value from India is $282.4K, based on 9 verified shipments in Indian Customs (DGFT) data.

What therapeutic categories does Phcedehop focus on?

Phcedehop imports across 1 categories. The largest: Advanced Oncology (100.0%).

Get Full Phcedehop Import Intelligence

Access shipment-level details, supplier connections, pricing data, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify import regulations and drug registration requirements with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. For current shipment-level data, contact TransData Nexus.

Phcedehop

Phcedehop — Import Portfolio & Supplier Network

Who Are the Verified Indian Suppliers to Phcedehop?

What Formulations Does Phcedehop Import?

What Products Does Phcedehop Import?

Top Products by Import Value

Phcedehop Therapeutic Categories — 1 Specializations